open access

Vol 66, No 2 (2015)
Original papers
Published online: 2015-05-01
Submitted: 2014-05-18
Accepted: 2014-09-16
Get Citation

The usefulness of the GHRH stimulation test in the diagnostics of growth hormone deficiency in children

Monika Obara-Moszyńska, Marek Niedziela
DOI: 10.5603/EP.2015.0021
·
Endokrynologia Polska 2015;66(2):137-141.

open access

Vol 66, No 2 (2015)
Original papers
Published online: 2015-05-01
Submitted: 2014-05-18
Accepted: 2014-09-16

Abstract

Introduction: Stimulation tests form the basis for the diagnostic process in growth hormone deficiency (GHD). One of these tests uses the GH releasing hormone (GHRH). This provides the potential to differentiate patients with pituitary dysfunction from patients with hypothalamus abnormalities. However, the routine use of the GHRH test is still being debated. The aim of this study was to assess the diagnostic usefulness of the GHRH test in the diagnostics of GHD.
Material and methods: The study group consisted of 20 prepubertal children with GHD. In all the children, one of the performed stimulation tests was the GHRH test.
Results: The results showed that the mean peak concentration of GH in the GHRH test was 14.7 ± 11.3 ng/mL. In eight children the MRI showed pituitary hypoplasia, in one patient pituitary hypoplasia and pituitary stalk agenesis, and in one patient septo-optic dysplasia. All patients with pituitary malformations, except for one patient with a hypoplastic pituitary gland, presented GH levels < 10 ng/mL in the GHRH test. The sensitivity of the GHRH test in the diagnostics of GHD was 45%.
Conclusions: The high correlation between the GHRH test and anatomical changes in the pituitary provides this test with a high predictive value. In individual clinical cases, knowledge about the level of damage in the hypothalamic-pituitary area can determine diagnostic and therapeutic procedures. (Endokrynol Pol 2015; 66 (2): 137–141)

Abstract

Introduction: Stimulation tests form the basis for the diagnostic process in growth hormone deficiency (GHD). One of these tests uses the GH releasing hormone (GHRH). This provides the potential to differentiate patients with pituitary dysfunction from patients with hypothalamus abnormalities. However, the routine use of the GHRH test is still being debated. The aim of this study was to assess the diagnostic usefulness of the GHRH test in the diagnostics of GHD.
Material and methods: The study group consisted of 20 prepubertal children with GHD. In all the children, one of the performed stimulation tests was the GHRH test.
Results: The results showed that the mean peak concentration of GH in the GHRH test was 14.7 ± 11.3 ng/mL. In eight children the MRI showed pituitary hypoplasia, in one patient pituitary hypoplasia and pituitary stalk agenesis, and in one patient septo-optic dysplasia. All patients with pituitary malformations, except for one patient with a hypoplastic pituitary gland, presented GH levels < 10 ng/mL in the GHRH test. The sensitivity of the GHRH test in the diagnostics of GHD was 45%.
Conclusions: The high correlation between the GHRH test and anatomical changes in the pituitary provides this test with a high predictive value. In individual clinical cases, knowledge about the level of damage in the hypothalamic-pituitary area can determine diagnostic and therapeutic procedures. (Endokrynol Pol 2015; 66 (2): 137–141)

Get Citation

Keywords

growth hormone deficiency; GHRH test; short stature; children

About this article
Title

The usefulness of the GHRH stimulation test in the diagnostics of growth hormone deficiency in children

Journal

Endokrynologia Polska

Issue

Vol 66, No 2 (2015)

Pages

137-141

Published online

2015-05-01

DOI

10.5603/EP.2015.0021

Bibliographic record

Endokrynologia Polska 2015;66(2):137-141.

Keywords

growth hormone deficiency
GHRH test
short stature
children

Authors

Monika Obara-Moszyńska
Marek Niedziela

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl